StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > $22,50

<< Previous

Bullboard Posts

Next >>

Comment by 4real4everon Mar 18, 2024 5:54pm

73 Views

Post# 35939275

RE:RE:$22,50

Yeah ATS where poor penny stocks need to look to see some movement

My bad a big $1000 more

When I speak or look at the shares traded it's only on TSX or V in CND I really don't care about the others

Remember the 8:1 consolidation for Nas LMAO

IainCaimbeul wrote: Actually on the ATS' it was 25,000 @ .04 = $1020.00, not great but at least accurate. Bash the stock all you want, just be factual.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario